InvestorsHub Logo
Followers 18
Posts 1381
Boards Moderated 0
Alias Born 07/29/2015

Re: None

Friday, 10/16/2015 1:23:25 PM

Friday, October 16, 2015 1:23:25 PM

Post# of 772
VTL has submitted a briefing document including a draft trial protocol to the FDA for the upcoming Type C written response meeting,